---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-085380"
form_type: "8-K"
ticker: "DSGN"
cik: "0001807120"
company_name: "Design Therapeutics, Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T11:05:05.543013+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Design Therapeutics stockholders elect directors and ratify auditor at 2025 annual meeting

## Summary
- Heather Berger, Ph.D., Rodney Lappe, Ph.D., and John Schmid elected as Class I directors to serve until 2028 annual meeting.
- Rodney Lappe received 32,799,677 votes for, 9,948,461 withheld, indicating notable opposition.
- Ernst & Young LLP ratified as independent auditor for FY2025 with 53,577,053 votes for, 2,731 against, 1,795 abstentions.
- A total of 56,768,678 shares were outstanding and entitled to vote as of the April 15, 2025 record date.

## SEC filing metadata
- accession: 0000950170-25-085380
- form_type: 8-K
- ticker: DSGN
- cik: 0001807120
- company_name: Design Therapeutics, Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1807120/000095017025085380/0000950170-25-085380-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1807120/000095017025085380/dsgn-20250610.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-085380
- JSON: https://secwatch.observer/filing/0000950170-25-085380.json
- Plain text: https://secwatch.observer/filing/0000950170-25-085380.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.